SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001654954-18-007795
Filing Date
2018-07-18
Accepted
2018-07-18 10:26:49
Documents
42
Period of Report
2018-05-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT qbio10q.htm 10-Q/A 496161
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit31.htm EX-31.1 19338
3 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE exhibit32.htm EX-32.1 8200
  Complete submission text file 0001654954-18-007795.txt   1644215

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT qbio-20180531.xml EX-101.INS 194041
5 XBRL TAXONOMY EXTENSION SCHEMA qbio-20180531.xsd EX-101.SCH 19027
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qbio-20180531_cal.xml EX-101.CAL 25848
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qbio-20180531_def.xml EX-101.DEF 22057
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE qbio-20180531_lab.xml EX-101.LAB 137847
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qbio-20180531_pre.xml EX-101.PRE 98634
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q/A | Act: 34 | File No.: 000-55535 | Film No.: 18957856
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1